Trevi Therapeutics, Inc.

Manufacturing · Pharmaceutical Preparations

完成交易日收盘US$13.86+1.69%行情日期 2026-11-03 · 非实时

公开资料页汇总Trevi Therapeutics, Inc.（TRVI）的已发布行情、估值、风险、财务摘要与同业对比。行情截至2026-11-03，非实时；缺失值不按零处理。

股价走势

复权收盘价（美元）

2025-10-31 — 2026-11-03253 个交易日样本

查看交易日数据

2026-11-03TRVIUS$13.86

查看图表数据

日期	TRVI
2025-10-31	11.66
2025-11-03	10.7
2025-11-04	10.86
2025-11-05	10.64
2025-11-06	11.01
2025-11-07	11.01
2025-11-10	11.67
2025-11-11	12.1
2025-11-12	11.85
2025-11-13	11.46
2025-11-14	11.37
2025-11-17	11.35
2025-11-18	11.31
2025-11-19	11.04
2025-11-20	10.65
2025-11-21	10.99
2025-11-24	11.41
2025-11-25	11.36
2025-11-26	13.29
2025-11-28	13.19
2025-12-01	13.3
2025-12-02	13.35
2025-12-03	13.7
2025-12-04	13.47
2025-12-05	13.47
2025-12-08	12.98
2025-12-09	12.99
2025-12-10	14.17
2025-12-11	13.17
2025-12-12	12.77
2025-12-15	12.61
2025-12-16	12.41
2025-12-17	12.11
2025-12-18	12.19
2025-12-19	13.01
2025-12-22	12.74
2025-12-23	12.82
2025-12-24	12.97
2025-12-26	12.85
2025-12-29	12.82
2025-12-30	12.56
2025-12-31	12.52
2026-01-02	11.89
2026-01-05	11.36
2026-01-06	10.98
2026-01-07	11.71
2026-01-08	11.21
2026-01-09	11.18
2026-01-12	11.29
2026-01-13	11.29
2026-01-14	11.44
2026-01-15	10.76
2026-01-16	10.48
2026-01-20	10.42
2026-01-21	10.3
2026-01-22	10.94
2026-01-23	9.99
2026-01-26	10.15
2026-01-27	10.96
2026-01-28	10.51
2026-01-29	10.69
2026-01-30	10.47
2026-02-02	10.96
2026-02-03	11.48
2026-02-04	11.45
2026-02-05	10.94
2026-02-06	11.46
2026-02-09	11.1
2026-02-10	11.25
2026-02-11	11.05
2026-02-12	10.94
2026-02-13	10.4
2026-02-17	10.15
2026-02-18	10.19
2026-02-19	10.56
2026-02-20	10.64
2026-02-23	11.1
2026-02-24	11.28
2026-02-25	11.36
2026-02-26	11.52
2026-02-27	11.92
2026-03-02	12.57
2026-03-03	12.26
2026-03-04	12.92
2026-03-05	13.08
2026-03-06	13.3
2026-03-09	11.7
2026-03-10	11.76
2026-03-11	11.94
2026-03-12	11.2
2026-03-13	11.01
2026-03-16	11.16
2026-03-17	11.19
2026-03-18	10.69
2026-03-19	10.7
2026-03-20	10.61
2026-03-23	10.76
2026-03-24	10.64
2026-03-25	11.44
2026-03-26	11.8
2026-03-27	11.33
2026-03-30	11.19
2026-03-31	11.93
2026-04-01	11.58
2026-04-02	11.94
2026-04-06	12.81
2026-04-07	13.1
2026-04-08	13.07
2026-04-09	13.3
2026-04-10	13.19
2026-04-13	13.33
2026-04-14	14.04
2026-04-15	14.27
2026-04-16	14.54
2026-04-17	15.23
2026-04-20	15.4
2026-04-21	14.62
2026-04-22	14.8
2026-04-23	14.19
2026-04-24	14.41
2026-04-27	14.27
2026-04-28	13.84
2026-04-29	13.82
2026-04-30	13.76
2026-05-01	13.87
2026-05-04	14.38
2026-05-05	14.66
2026-05-06	14.26
2026-05-07	14.05
2026-05-08	14.5
2026-05-11	14.88
2026-05-12	14.76
2026-05-13	15.27
2026-05-14	15.08
2026-05-15	14.2
2026-05-18	13.43
2026-05-19	13.24
2026-05-20	13.88
2026-05-21	14.16
2026-05-22	14.13
2026-05-26	14.38
2026-05-27	14.45
2026-05-28	14.45
2026-05-29	14.14
2026-06-01	13.95
2026-06-02	13.5
2026-06-03	13.45
2026-06-04	13.93
2026-06-05	13.33
2026-06-08	13.5
2026-06-09	13.59
2026-06-10	13.4
2026-06-11	13.46
2026-06-12	14.21
2026-06-15	14.66
2026-06-16	15.4
2026-06-17	16.37
2026-06-18	17.21
2026-06-22	17.71
2026-06-23	17.38
2026-06-24	17.52
2026-06-25	18
2026-06-26	18.15
2026-06-29	18.63
2026-06-30	18.65
2026-07-01	17.61
2026-07-02	17.93
2026-07-06	17.95
2026-07-07	19.5
2026-07-08	18.59
2026-07-09	18.4
2026-07-10	17.84
2026-07-13	16.52
2026-07-14	17.91
2026-07-15	18.15
2026-07-16	17.36
2026-07-17	19.07
2026-07-20	16.77
2026-07-21	18.18
2026-07-22	17.36
2026-07-23	17.18
2026-07-24	17.54
2026-07-27	18.12
2026-07-28	18.43
2026-07-29	18.09
2026-07-30	18.4
2026-07-31	18.25
2026-08-03	17.9
2026-08-04	18.75
2026-08-05	18.65
2026-08-06	18.5
2026-08-07	18.51
2026-08-10	17.8
2026-08-11	17.8
2026-08-12	17.73
2026-08-13	18.15
2026-08-14	18.46
2026-08-17	18.48
2026-08-18	18.84
2026-08-19	18.81
2026-08-20	18.25
2026-08-21	17.96
2026-08-24	18.08
2026-08-25	17.95
2026-08-26	17.92
2026-08-27	17.96
2026-08-28	16.79
2026-08-31	16.6
2026-09-01	16.57
2026-09-02	17.05
2026-09-03	17.06
2026-09-04	17.26
2026-09-08	16.82
2026-09-09	16.64
2026-09-10	15.91
2026-09-11	15.9
2026-09-14	15.89
2026-09-15	15.04
2026-09-16	15.01
2026-09-17	15.21
2026-09-18	14.95
2026-09-21	14.89
2026-09-22	15.24
2026-09-23	14.46
2026-09-24	14.68
2026-09-25	14.41
2026-09-28	14.4
2026-09-29	14.42
2026-09-30	14.32
2026-10-01	14.18
2026-10-02	13.91
2026-10-05	13.72
2026-10-06	13.18
2026-10-07	13.14
2026-10-08	12.83
2026-10-09	13.19
2026-10-12	12.93
2026-10-13	12.29
2026-10-14	12.06
2026-10-15	12.11
2026-10-16	11.88
2026-10-19	11.9
2026-10-20	12.83
2026-10-21	12.77
2026-10-22	12.94
2026-10-23	12.61
2026-10-26	12.51
2026-10-27	13.35
2026-10-28	13.52
2026-10-29	13.81
2026-10-30	13.56
2026-11-02	13.63
2026-11-03	13.86

1、3、6、12个月分别按21、63、126、252个交易日取区间；缺失日期不从区间外补齐。

使用已有每日复权收盘样本，非实时行情；图中价格可能与未复权收盘报价不同。

01 · MARKET FRAME

行情、估值与风险

基于已完成交易日和已发布财务资料

市值US$2B

市盈率（TTM）—

自由现金流收益率-2.1%

距52周高点-28.9%

近一年波动率+57.5%

近一年最大回撤-39.1%

区间涨跌幅

10日+8%起点 2026-10-20

30日-9.1%起点 2026-09-22

90日-23.6%起点 2026-06-26

180日+36.6%起点 2026-02-17

250日+27.6%起点 2025-11-04

区间涨跌幅使用复权收盘价；估值和风险指标缺失时显示为—，不按零处理。

02 · FINANCIAL TRACE

财务摘要

公开页仅显示最近3个已校验报告期

年度财务走势

百万美元 · 年度报告期

所选指标暂无已校验的年度资料，缺失值不按零处理。

指标	2026-07-31	2026-06-30	2025-12-31	2025-07-31	2025-06-30	2024-12-31	2024-07-31	2024-06-30	2023-12-31
营收	—	—	—	—	—	—	—	—	—
净利润	—	—	-42.8	—	—	-47.9	—	—	-29.1
自由现金流	—	—	-42.1	—	—	-38.3	—	—	-31.8
股份数	142.5	—	—	121.8	—	—	72.6	—	—
债务	—	—	—	—	—	—	—	—	—
总资产	—	330.5	—	—	208.3	—	—	73.8	—

金额及股份数均以百万为单位。缺失或待核验数据不按零处理。

03 · PEER SET

同业对比

同一细分行业中市值最接近的公司

公司	市值	近250日涨跌幅	市盈率	距52周高点	波动率
SRPT萨瑞塔医疗	US$2B	+14.4%	—	-24.2%	+79.2%
MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.	US$1.9B	+159.6%	—	-17.2%	+69.9%
BRVEBraveheart Bio, Inc.	US$1.9B	—	—	—	—
SDGR薛定谔	US$2B	+36%	—	-16.6%	+65.7%

同业由已覆盖公司的行业分类和市值接近度确定，仅用于横向研究；缺失数据不按零处理。